Cargando…

Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples

BACKGROUND: Cervical-vaginal fluid (CVF) plays an important role in the prevention of gynecological infections, although little is known about the contribution of CVF proteins to the immunity of the lower female genital tract. In order to analyze the protein composition of human CVF, we used CVF sam...

Descripción completa

Detalles Bibliográficos
Autores principales: Zegels, Geert, Van Raemdonck, Geert AA, Coen, Edmond P, Tjalma, Wiebren AA, Van Ostade, Xaveer WM
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678104/
https://www.ncbi.nlm.nih.gov/pubmed/19374746
http://dx.doi.org/10.1186/1477-5956-7-17
_version_ 1782166818589245440
author Zegels, Geert
Van Raemdonck, Geert AA
Coen, Edmond P
Tjalma, Wiebren AA
Van Ostade, Xaveer WM
author_facet Zegels, Geert
Van Raemdonck, Geert AA
Coen, Edmond P
Tjalma, Wiebren AA
Van Ostade, Xaveer WM
author_sort Zegels, Geert
collection PubMed
description BACKGROUND: Cervical-vaginal fluid (CVF) plays an important role in the prevention of gynecological infections, although little is known about the contribution of CVF proteins to the immunity of the lower female genital tract. In order to analyze the protein composition of human CVF, we used CVF samples that are routinely collected during colposcopy, but are usually discarded. Since these samples are available in large quantities we aimed to analyze their usefulness for proteomics experiments. The samples were analyzed using different prefractionation techniques (ultrafiltration and C(4)(RP)-LC protein separation) followed by C(18)(RP)-LC peptide separation and identification by MALDI-TOF-TOF mass spectrometry. To determine the reproducibility of this proteomics platform we analyzed three technical replicates. Using spectral counting, protein abundances were estimated in a semiquantitative way. We also compared the results obtained in this study with those from previous studies derived from patients with different physiological conditions in order to determine an overlapping protein set. RESULTS: In total, we were able to identify 339 proteins in human CVF of which 151 proteins were not identified in any other proteomics study on human CVF so far. Those included antimicrobial peptides, such as human beta-defensin 2 and cathelicidin, which were known to be present in CVF, and endometrial proteins such as glycodelin and ribonucleoprotein A. Comparison of our results with previously published data led to the identification of a common protein set of 136 proteins. This overlapping protein set shows increased fractions of immunological and extracellular proteins, confirming the extracellular immunological role of CVF. CONCLUSION: We demonstrated here that CVF colposcopy samples can be used in proteomics experiments and hence are applicable for biomarker discovery experiments. The delineation of an overlapping set of proteins that is identified in most proteomics studies on CVF may help in the description of a reference proteome when performing proteomics studies on human CVF.
format Text
id pubmed-2678104
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26781042009-05-07 Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples Zegels, Geert Van Raemdonck, Geert AA Coen, Edmond P Tjalma, Wiebren AA Van Ostade, Xaveer WM Proteome Sci Research BACKGROUND: Cervical-vaginal fluid (CVF) plays an important role in the prevention of gynecological infections, although little is known about the contribution of CVF proteins to the immunity of the lower female genital tract. In order to analyze the protein composition of human CVF, we used CVF samples that are routinely collected during colposcopy, but are usually discarded. Since these samples are available in large quantities we aimed to analyze their usefulness for proteomics experiments. The samples were analyzed using different prefractionation techniques (ultrafiltration and C(4)(RP)-LC protein separation) followed by C(18)(RP)-LC peptide separation and identification by MALDI-TOF-TOF mass spectrometry. To determine the reproducibility of this proteomics platform we analyzed three technical replicates. Using spectral counting, protein abundances were estimated in a semiquantitative way. We also compared the results obtained in this study with those from previous studies derived from patients with different physiological conditions in order to determine an overlapping protein set. RESULTS: In total, we were able to identify 339 proteins in human CVF of which 151 proteins were not identified in any other proteomics study on human CVF so far. Those included antimicrobial peptides, such as human beta-defensin 2 and cathelicidin, which were known to be present in CVF, and endometrial proteins such as glycodelin and ribonucleoprotein A. Comparison of our results with previously published data led to the identification of a common protein set of 136 proteins. This overlapping protein set shows increased fractions of immunological and extracellular proteins, confirming the extracellular immunological role of CVF. CONCLUSION: We demonstrated here that CVF colposcopy samples can be used in proteomics experiments and hence are applicable for biomarker discovery experiments. The delineation of an overlapping set of proteins that is identified in most proteomics studies on CVF may help in the description of a reference proteome when performing proteomics studies on human CVF. BioMed Central 2009-04-17 /pmc/articles/PMC2678104/ /pubmed/19374746 http://dx.doi.org/10.1186/1477-5956-7-17 Text en Copyright © 2009 Zegels et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Zegels, Geert
Van Raemdonck, Geert AA
Coen, Edmond P
Tjalma, Wiebren AA
Van Ostade, Xaveer WM
Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples
title Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples
title_full Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples
title_fullStr Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples
title_full_unstemmed Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples
title_short Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples
title_sort comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678104/
https://www.ncbi.nlm.nih.gov/pubmed/19374746
http://dx.doi.org/10.1186/1477-5956-7-17
work_keys_str_mv AT zegelsgeert comprehensiveproteomicanalysisofhumancervicalvaginalfluidusingcolposcopysamples
AT vanraemdonckgeertaa comprehensiveproteomicanalysisofhumancervicalvaginalfluidusingcolposcopysamples
AT coenedmondp comprehensiveproteomicanalysisofhumancervicalvaginalfluidusingcolposcopysamples
AT tjalmawiebrenaa comprehensiveproteomicanalysisofhumancervicalvaginalfluidusingcolposcopysamples
AT vanostadexaveerwm comprehensiveproteomicanalysisofhumancervicalvaginalfluidusingcolposcopysamples